Don’t forget to register for our very first Mayo Clinic GN course happening Oct 2nd and 3rd! We have an amazing lineup of expert with many case-based sessions. @fervenzaf@LeticiaRolonMD@SethiRenalPath
Link below:
https://t.co/Sa07n8rhS0
At the start of the @glomcon Richard Glassock Endowed Lectureship, @fervenzaf honors the legacy of @GlassockJ , reflecting on his remarkable career, immeasurable contributions to nephrology, and the enduring friendship they shared. #GlomconHawaii26
Now that the dust has settled, I am extremely grateful and honored to be the head coach at Friends University. Welcoming baby #2 and taking a new job in the same week isn’t for the weak, but we welcome the adversity!
Keep moving forward
Stay up to date with the latest advances in glomerular disease and kidney pathology! We have an incredible line up of expert speakers! Don’t miss out. See below for more details. Register today!
New course! Selected Topics in Glomerular Diseases and Kidney Pathology 2026 is October 2-3 in Minnesota and via livestream. @MayoClinicNeph experts will cover diagnostic approaches, biomarkers, classification systems, and evidence-based management. https://t.co/c2gz6mThH9
If you want to learn more about glomerular diseases, don’t miss this opportunity to hear from 🌍 world-renowned experts with unparalleled clinical experience check this out👇🏽@MayoClinicNeph directors @LadanZand@fervenzaf@LeticiaRolonMD
Looking forward to spending the week in Glasgow at the 2026 ERA Congress! GN efforts continue to accelerate!
If you're at ERA26 and would like to connect, feel free to reach out or stop by the Roche Medical booth (#310).
#ERA26#Nephrology#GlomerularDisease#MedicalAffairs
Just published!!!
Our review on strategies to mitigate infection risk with complement inhibitors, highlighting real-world gaps in guidance, where evidence is limited and clinical judgement is key - vaccines, antibiotics, specialist consults @CIDJournal
https://t.co/QYD6M7TnXX
This “complements” our earlier paper in @asnpublications (which outlined infection risk broadly in kidney disease) by digging into how to operationalize prevention in practice!
https://t.co/6TE6hA0F4G
#complementinhibitors #patientsafety
We’re delighted to share the Fall 2025 edition of our @WashUNephrology Newsletter. This issue highlights the accomplishments of our faculty & staff, w/ exciting updates in research, clinical innovation, & education. Follow link to see all that is new!
https://t.co/sNEyzqvdGT
@SaynaNorouzi How was navigating the airport on arrival? I'm reading about many issues for folks leaving Houston but how about incoming? I'll be there tomorrow!
🔥 Brilliant session by the legendary Dr. Glassock at the #GlomCon Fellowship!
Limiting #LupusNephritis flares is JUST as important as treatment.
✅ Prevent relapses → ↓ risk of #ESKD
🎯 Goal: Immunological remission (normal complements, neg. anti-dsDNA)
#NephX#LN@GlomCon Fellowship Program
@GlassockJ
What a conference! Amazing location and even better company and presenters. Kudos to @SaynaNorouzi and the @GlomCon team. I'm elated to finally be working in the kidney space 🫘 #GlomConHawaii#GlomCon25
1 of the many highlights of #GlomConHawaii - getting to meet @kidney_boy IRL and thanking him for all of his #nephrology#meded - these podcasts and blog posts were required listenings and readings for Na+ topic discussions I used to lead in the NeuroICU. Cant wait for #GlomCon26
Very insightful panel discussion with @US_FDA Dr Thompson regarding clinical trials in pediatric patients with glomerular disease #GlomConHawaii#glomcon
That’s a wrap on an unforgettable GN Symposium 🎬 Expert talks, case panels, and nonstop learning with the best in the field. See you next year! 💙 #WashUNephrology#nephstrong